Dosing clopidogrel based on CYP2C19 genotype and the effect on platelet reactivity in patients with stable cardiovascular disease Academic Article uri icon

Overview

MeSH Major

  • Aryl Hydrocarbon Hydroxylases
  • Cardiovascular Diseases
  • Platelet Activation
  • Platelet Aggregation Inhibitors
  • Ticlopidine

abstract

  • clinicaltrials.gov Identifier: NCT01235351.

publication date

  • November 23, 2011

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1001/jama.2011.1703

PubMed ID

  • 22088980

Additional Document Info

start page

  • 2221

end page

  • 8

volume

  • 306

number

  • 20